Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 51 entries
Sorted by: Best Match Show Resources per page
Irritable bowel syndrome and diet.

Gastroenterology report

Portincasa P, Bonfrate L, de Bari O, Lembo A, Ballou S.
PMID: 28110300
Gastroenterol Rep (Oxf). 2017 Feb;5(1):11-19. doi: 10.1093/gastro/gow047. Epub 2017 Jan 20.

Irritable bowel syndrome (IBS) is a chronic functional disorder of the gastrointestinal tract and is one of the most commonly diagnosed gastrointestinal diseases. The impact of IBS on the general population is large due to its high prevalence, suboptimal...

Cite
Portincasa P, Bonfrate L, de Bari O, et al. Irritable bowel syndrome and diet. Gastroenterol Rep (Oxf). 2017;5(1):11-19doi: 10.1093/gastro/gow047.
Portincasa, P., Bonfrate, L., de Bari, O., Lembo, A., & Ballou, S. (2017). Irritable bowel syndrome and diet. Gastroenterology report, 5(1), 11-19. https://doi.org/10.1093/gastro/gow047
Portincasa, Piero, et al. "Irritable bowel syndrome and diet." Gastroenterology report vol. 5,1 (2017): 11-19. doi: https://doi.org/10.1093/gastro/gow047
Portincasa P, Bonfrate L, de Bari O, Lembo A, Ballou S. Irritable bowel syndrome and diet. Gastroenterol Rep (Oxf). 2017 Feb;5(1):11-19. doi: 10.1093/gastro/gow047. Epub 2017 Jan 20. PMID: 28110300; PMCID: PMC5444258.
Copy Download .nbib Format: NLM
Epilepsy triggered by mefloquine in an adult traveler to Uganda.

World journal of clinical cases

Gobbi F, Rossanese A, Buonfrate D, Angheben A, Postiglione C, Bisoffi Z.
PMID: 24527427
World J Clin Cases. 2014 Jan 16;2(1):12-5. doi: 10.12998/wjcc.v2.i1.12.

We report a case of a traveler who visited Uganda for 8 d, and took mefloquine one tablet/week for malaria prophylaxis. After the second dose, he suffered from two episodes of loss of consciousness with seizures, therefore mefloquine was...

Cite
Gobbi F, Rossanese A, Buonfrate D, et al. Epilepsy triggered by mefloquine in an adult traveler to Uganda. World J Clin Cases. 2014;2(1):12-5doi: 10.12998/wjcc.v2.i1.12.
Gobbi, F., Rossanese, A., Buonfrate, D., Angheben, A., Postiglione, C., & Bisoffi, Z. (2014). Epilepsy triggered by mefloquine in an adult traveler to Uganda. World journal of clinical cases, 2(1), 12-5. https://doi.org/10.12998/wjcc.v2.i1.12
Gobbi, Federico, et al. "Epilepsy triggered by mefloquine in an adult traveler to Uganda." World journal of clinical cases vol. 2,1 (2014): 12-5. doi: https://doi.org/10.12998/wjcc.v2.i1.12
Gobbi F, Rossanese A, Buonfrate D, Angheben A, Postiglione C, Bisoffi Z. Epilepsy triggered by mefloquine in an adult traveler to Uganda. World J Clin Cases. 2014 Jan 16;2(1):12-5. doi: 10.12998/wjcc.v2.i1.12. PMID: 24527427; PMCID: PMC3920231.
Copy Download .nbib Format: NLM
Research update for articles published in EJCI in 2017.

European journal of clinical investigation

Arellano-Orden E, Bacopoulou F, Baicus C, Bonfrate L, Broadbent J, Buechler C, Carbone F, Charmandari E, Davis GR, Dullaart RPF, Efthymiou V, Goeser F, Goswami N, Jong GP, Lichtenauer M, Liou YS, Lutz P, Maeng M, Mert GÖ, Mert KU, Montecucco F, Ndrepepa G, Olesen KKW, Oliveira P, Perton FG, Portincasa P, Rodriguez-Panadero F, Schernthaner C, Schutte R.
PMID: 31524285
Eur J Clin Invest. 2019 Oct;49(10):e13163. doi: 10.1111/eci.13163. Epub 2019 Sep 16.

No abstract available.

Cite
Arellano-Orden E, Bacopoulou F, Baicus C, et al. Research update for articles published in EJCI in 2017. Eur J Clin Invest. 2019;49(10):e13163doi: 10.1111/eci.13163.
Arellano-Orden, E., Bacopoulou, F., Baicus, C., Bonfrate, L., Broadbent, J., Buechler, C., Carbone, F., Charmandari, E., Davis, G. R., Dullaart, R. P. F., Efthymiou, V., Goeser, F., Goswami, N., Jong, G. P., Lichtenauer, M., Liou, Y. S., Lutz, P., Maeng, M., Mert, G. �. �., Mert, K. U., Montecucco, F., Ndrepepa, G., Olesen, K. K. W., Oliveira, P., Perton, F. G., Portincasa, P., Rodriguez-Panadero, F., Schernthaner, C., & Schutte, R. (2019). Research update for articles published in EJCI in 2017. European journal of clinical investigation, 49(10), e13163. https://doi.org/10.1111/eci.13163
Arellano-Orden, Elena, et al. "Research update for articles published in EJCI in 2017." European journal of clinical investigation vol. 49,10 (2019): e13163. doi: https://doi.org/10.1111/eci.13163
Arellano-Orden E, Bacopoulou F, Baicus C, Bonfrate L, Broadbent J, Buechler C, Carbone F, Charmandari E, Davis GR, Dullaart RPF, Efthymiou V, Goeser F, Goswami N, Jong GP, Lichtenauer M, Liou YS, Lutz P, Maeng M, Mert GÖ, Mert KU, Montecucco F, Ndrepepa G, Olesen KKW, Oliveira P, Perton FG, Portincasa P, Rodriguez-Panadero F, Schernthaner C, Schutte R. Research update for articles published in EJCI in 2017. Eur J Clin Invest. 2019 Oct;49(10):e13163. doi: 10.1111/eci.13163. Epub 2019 Sep 16. PMID: 31524285.
Copy Download .nbib Format: NLM
Supramolecular Chiral Discrimination of D-Phenylalanine Amino Acid Based on a Perylene Bisimide Derivative.

Frontiers in bioengineering and biotechnology

Bettini S, Syrgiannis Z, Ottolini M, Bonfrate V, Giancane G, Valli L, Prato M.
PMID: 32195240
Front Bioeng Biotechnol. 2020 Mar 04;8:160. doi: 10.3389/fbioe.2020.00160. eCollection 2020.

The interaction between homochiral substituted perylene bisimide (PBI) molecule and the D enantiomer of phenylalanine amino acid was monitored. Spectroscopic transitions of PBI derivative in aqueous solution in the visible range were used to evaluate the presence of D-phenylalanine....

Cite
Bettini S, Syrgiannis Z, Ottolini M, et al. Supramolecular Chiral Discrimination of D-Phenylalanine Amino Acid Based on a Perylene Bisimide Derivative. Front Bioeng Biotechnol. 2020;8:160doi: 10.3389/fbioe.2020.00160.
Bettini, S., Syrgiannis, Z., Ottolini, M., Bonfrate, V., Giancane, G., Valli, L., & Prato, M. (2020). Supramolecular Chiral Discrimination of D-Phenylalanine Amino Acid Based on a Perylene Bisimide Derivative. Frontiers in bioengineering and biotechnology, 8160. https://doi.org/10.3389/fbioe.2020.00160
Bettini, Simona, et al. "Supramolecular Chiral Discrimination of D-Phenylalanine Amino Acid Based on a Perylene Bisimide Derivative." Frontiers in bioengineering and biotechnology vol. 8 (2020): 160. doi: https://doi.org/10.3389/fbioe.2020.00160
Bettini S, Syrgiannis Z, Ottolini M, Bonfrate V, Giancane G, Valli L, Prato M. Supramolecular Chiral Discrimination of D-Phenylalanine Amino Acid Based on a Perylene Bisimide Derivative. Front Bioeng Biotechnol. 2020 Mar 04;8:160. doi: 10.3389/fbioe.2020.00160. eCollection 2020. PMID: 32195240; PMCID: PMC7064719.
Copy Download .nbib Format: NLM
Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Buonfrate D, Piubelli C, Gobbi F, Martini D, Bertoli G, Ursini T, Moro L, Ronzoni N, Angheben A, Rodari P, Cardellino C, Tamarozzi F, Tais S, Rizzi E, Degani M, Deiana M, Prato M, Silva R, Bisoffi Z.
PMID: 34329793
Clin Microbiol Infect. 2021 Dec;27(12):1845-1850. doi: 10.1016/j.cmi.2021.07.024. Epub 2021 Jul 28.

OBJECTIVES: To assess the antibody response to BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers (HCW), comparing individuals with previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and SARS-CoV-2-naive individuals.METHODS: HCW were tested at T0 (day...

Cite
Buonfrate D, Piubelli C, Gobbi F, et al. Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study. Clin Microbiol Infect. 2021;27(12):1845-1850doi: 10.1016/j.cmi.2021.07.024.
Buonfrate, D., Piubelli, C., Gobbi, F., Martini, D., Bertoli, G., Ursini, T., Moro, L., Ronzoni, N., Angheben, A., Rodari, P., Cardellino, C., Tamarozzi, F., Tais, S., Rizzi, E., Degani, M., Deiana, M., Prato, M., Silva, R., & Bisoffi, Z. (2021). Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 27(12), 1845-1850. https://doi.org/10.1016/j.cmi.2021.07.024
Buonfrate, Dora, et al. "Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study." Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. 27,12 (2021): 1845-1850. doi: https://doi.org/10.1016/j.cmi.2021.07.024
Buonfrate D, Piubelli C, Gobbi F, Martini D, Bertoli G, Ursini T, Moro L, Ronzoni N, Angheben A, Rodari P, Cardellino C, Tamarozzi F, Tais S, Rizzi E, Degani M, Deiana M, Prato M, Silva R, Bisoffi Z. Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study. Clin Microbiol Infect. 2021 Dec;27(12):1845-1850. doi: 10.1016/j.cmi.2021.07.024. Epub 2021 Jul 28. PMID: 34329793; PMCID: PMC8316640.
Copy Download .nbib Format: NLM
Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine.

The Journal of infection

Gobbi F, Buonfrate D, Silva R, Martini D, Bisoffi Z, Piubelli C, Riccetti S, Sinigaglia A, Barzon L.
PMID: 34371075
J Infect. 2022 Jan;84(1):94-118. doi: 10.1016/j.jinf.2021.08.008. Epub 2021 Aug 08.

No abstract available.

Cite
Gobbi F, Buonfrate D, Silva R, et al. Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine. J Infect. 2021;84(1):94-118doi: 10.1016/j.jinf.2021.08.008.
Gobbi, F., Buonfrate, D., Silva, R., Martini, D., Bisoffi, Z., Piubelli, C., Riccetti, S., Sinigaglia, A., & Barzon, L. (2022). Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine. The Journal of infection, 84(1), 94-118. https://doi.org/10.1016/j.jinf.2021.08.008
Gobbi, Federico, et al. "Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine." The Journal of infection vol. 84,1 (2022): 94-118. doi: https://doi.org/10.1016/j.jinf.2021.08.008
Gobbi F, Buonfrate D, Silva R, Martini D, Bisoffi Z, Piubelli C, Riccetti S, Sinigaglia A, Barzon L. Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine. J Infect. 2022 Jan;84(1):94-118. doi: 10.1016/j.jinf.2021.08.008. Epub 2021 Aug 08. PMID: 34371075; PMCID: PMC8349413.
Copy Download .nbib Format: NLM
C-Reactive Protein for the Early Assessment of Non-Malarial Febrile Patients: A Retrospective Diagnostic Study.

Diagnostics (Basel, Switzerland)

Bertoli G, Mazzi C, Ronzoni N, Silva R, Spinicci M, Pozzi M, Sponga P, Aiello A, Ursini T, Bartoloni A, Olliaro P, Bisoffi Z, Buonfrate D.
PMID: 34574070
Diagnostics (Basel). 2021 Sep 20;11(9). doi: 10.3390/diagnostics11091728.

Biomarkers, especially CRP, have demonstrated their relevance to differentiate viral from bacterial infection, even though a reliable threshold is far to being found. In low- and middle-income countries, affordable and user-friendly rapid diagnostic tests based on biomarkers can be...

Cite
Bertoli G, Mazzi C, Ronzoni N, et al. C-Reactive Protein for the Early Assessment of Non-Malarial Febrile Patients: A Retrospective Diagnostic Study. Diagnostics (Basel). 2021;11(9)doi: 10.3390/diagnostics11091728.
Bertoli, G., Mazzi, C., Ronzoni, N., Silva, R., Spinicci, M., Pozzi, M., Sponga, P., Aiello, A., Ursini, T., Bartoloni, A., Olliaro, P., Bisoffi, Z., & Buonfrate, D. (2021). C-Reactive Protein for the Early Assessment of Non-Malarial Febrile Patients: A Retrospective Diagnostic Study. Diagnostics (Basel, Switzerland), 11(9), . https://doi.org/10.3390/diagnostics11091728
Bertoli, Giulia, et al. "C-Reactive Protein for the Early Assessment of Non-Malarial Febrile Patients: A Retrospective Diagnostic Study." Diagnostics (Basel, Switzerland) vol. 11,9 (2021). doi: https://doi.org/10.3390/diagnostics11091728
Bertoli G, Mazzi C, Ronzoni N, Silva R, Spinicci M, Pozzi M, Sponga P, Aiello A, Ursini T, Bartoloni A, Olliaro P, Bisoffi Z, Buonfrate D. C-Reactive Protein for the Early Assessment of Non-Malarial Febrile Patients: A Retrospective Diagnostic Study. Diagnostics (Basel). 2021 Sep 20;11(9). doi: 10.3390/diagnostics11091728. PMID: 34574070; PMCID: PMC8469932.
Copy Download .nbib Format: NLM
Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin.

European journal of clinical investigation

Bonfrate L, Di Ciaula A, Portincasa P.
PMID: 34738648
Eur J Clin Invest. 2021 Nov 05;e13702. doi: 10.1111/eci.13702. Epub 2021 Nov 05.

No abstract available.

Cite
Bonfrate L, Di Ciaula A, Portincasa P. Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin. Eur J Clin Invest. 2021;e13702doi: 10.1111/eci.13702.
Bonfrate, L., Di Ciaula, A., & Portincasa, P. (2021). Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin. European journal of clinical investigation, e13702. https://doi.org/10.1111/eci.13702
Bonfrate, Leonilde, et al. "Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin." European journal of clinical investigation vol. (2021): e13702. doi: https://doi.org/10.1111/eci.13702
Bonfrate L, Di Ciaula A, Portincasa P. Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin. Eur J Clin Invest. 2021 Nov 05;e13702. doi: 10.1111/eci.13702. Epub 2021 Nov 05. PMID: 34738648.
Copy Download .nbib Format: NLM
Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin.

European journal of clinical investigation

Bonfrate L, Di Ciaula A, Portincasa P.
PMID: 34738648
Eur J Clin Invest. 2022 Jan;52(1):e13702. doi: 10.1111/eci.13702. Epub 2021 Nov 05.

No abstract available.

Cite
Bonfrate L, Di Ciaula A, Portincasa P. Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin. Eur J Clin Invest. 2021;52(1):e13702doi: 10.1111/eci.13702.
Bonfrate, L., Di Ciaula, A., & Portincasa, P. (2022). Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin. European journal of clinical investigation, 52(1), e13702. https://doi.org/10.1111/eci.13702
Bonfrate, Leonilde, et al. "Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin." European journal of clinical investigation vol. 52,1 (2022): e13702. doi: https://doi.org/10.1111/eci.13702
Bonfrate L, Di Ciaula A, Portincasa P. Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin. Eur J Clin Invest. 2022 Jan;52(1):e13702. doi: 10.1111/eci.13702. Epub 2021 Nov 05. PMID: 34738648.
Copy Download .nbib Format: NLM
Oxidative stress, inflammation, and peritoneal dialysis: A molecular biology approach.

Artificial organs

Innico G, Gobbi L, Bertoldi G, Rigato M, Basso A, Bonfante L, Calò LA.
PMID: 34037984
Artif Organs. 2021 Oct;45(10):1202-1207. doi: 10.1111/aor.14001. Epub 2021 Jun 15.

The key role of oxidative stress (OxSt) and inflammation for the induction of cardiovascular disease, the leading cause of excess morbidity/mortality in chronic kidney disease and dialysis patients, is known and both the activations of NADPH oxidase and RhoA/Rho...

Cite
Innico G, Gobbi L, Bertoldi G, et al. Oxidative stress, inflammation, and peritoneal dialysis: A molecular biology approach. Artif Organs. 2021;45(10):1202-1207doi: 10.1111/aor.14001.
Innico, G., Gobbi, L., Bertoldi, G., Rigato, M., Basso, A., Bonfante, L., & Calò, L. A. (2021). Oxidative stress, inflammation, and peritoneal dialysis: A molecular biology approach. Artificial organs, 45(10), 1202-1207. https://doi.org/10.1111/aor.14001
Innico, Georgie, et al. "Oxidative stress, inflammation, and peritoneal dialysis: A molecular biology approach." Artificial organs vol. 45,10 (2021): 1202-1207. doi: https://doi.org/10.1111/aor.14001
Innico G, Gobbi L, Bertoldi G, Rigato M, Basso A, Bonfante L, Calò LA. Oxidative stress, inflammation, and peritoneal dialysis: A molecular biology approach. Artif Organs. 2021 Oct;45(10):1202-1207. doi: 10.1111/aor.14001. Epub 2021 Jun 15. PMID: 34037984; PMCID: PMC8519152.
Copy Download .nbib Format: NLM
Autochthonous Human and Canine .

Pathogens (Basel, Switzerland)

Ottino L, Buonfrate D, Paradies P, Bisoffi Z, Antonelli A, Rossolini GM, Gabrielli S, Bartoloni A, Zammarchi L.
PMID: 32503315
Pathogens. 2020 Jun 03;9(6). doi: 10.3390/pathogens9060439.

Autochthonous human and canine strongyloidiasis is reported in Europe but is unclear whether the transmission of infection still occurs. We report a previously unpublished human case in an Italian teen and perform a systematic review of literature on autochthonous...

Cite
Ottino L, Buonfrate D, Paradies P, et al. Autochthonous Human and Canine . Pathogens. 2020;9(6)doi: 10.3390/pathogens9060439.
Ottino, L., Buonfrate, D., Paradies, P., Bisoffi, Z., Antonelli, A., Rossolini, G. M., Gabrielli, S., Bartoloni, A., & Zammarchi, L. (2020). Autochthonous Human and Canine . Pathogens (Basel, Switzerland), 9(6), . https://doi.org/10.3390/pathogens9060439
Ottino, Letizia, et al. "Autochthonous Human and Canine ." Pathogens (Basel, Switzerland) vol. 9,6 (2020). doi: https://doi.org/10.3390/pathogens9060439
Ottino L, Buonfrate D, Paradies P, Bisoffi Z, Antonelli A, Rossolini GM, Gabrielli S, Bartoloni A, Zammarchi L. Autochthonous Human and Canine . Pathogens. 2020 Jun 03;9(6). doi: 10.3390/pathogens9060439. PMID: 32503315; PMCID: PMC7350350.
Copy Download .nbib Format: NLM
Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk.

Journal of clinical medicine

Di Ciaula A, Baj J, Garruti G, Celano G, De Angelis M, Wang HH, Di Palo DM, Bonfrate L, Wang DQ, Portincasa P.
PMID: 32823983
J Clin Med. 2020 Aug 14;9(8). doi: 10.3390/jcm9082648.

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide and parallels comorbidities such as obesity, metabolic syndrome, dyslipidemia, and diabetes. Recent studies describe the presence of NAFLD in non-obese individuals, with mechanisms partially independent from excessive caloric...

Cite
Di Ciaula A, Baj J, Garruti G, et al. Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk. J Clin Med. 2020;9(8)doi: 10.3390/jcm9082648.
Di Ciaula, A., Baj, J., Garruti, G., Celano, G., De Angelis, M., Wang, H. H., Di Palo, D. M., Bonfrate, L., Wang, D. Q., & Portincasa, P. (2020). Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk. Journal of clinical medicine, 9(8), . https://doi.org/10.3390/jcm9082648
Di Ciaula, Agostino, et al. "Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk." Journal of clinical medicine vol. 9,8 (2020). doi: https://doi.org/10.3390/jcm9082648
Di Ciaula A, Baj J, Garruti G, Celano G, De Angelis M, Wang HH, Di Palo DM, Bonfrate L, Wang DQ, Portincasa P. Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk. J Clin Med. 2020 Aug 14;9(8). doi: 10.3390/jcm9082648. PMID: 32823983; PMCID: PMC7465294.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 51 entries